Latest AJCC Edition Staging System May Not Be As Effective in Differentiating Survival in Melanoma

An external validation of the American Joint Committee on Cancer (AJCC) 8th edition staging system found that the latest edition maintained a similar prognostic accuracy as its predecessor

BMS’ Opdivo cuts risk of melanoma recurrence

Bristol-Myers Squibb’s Opdivo, which is being investigated as adjuvant treatment after surgery for stage IIIb/c or IV melanoma patients at high risk of recurrence, may significantly cut the risk of patients’ cancer returning at 24 months versus Yervoy.

Nivolumab More Effective Than Ipilimumab in Resected High-Risk Melanoma

Extended follow-up from the CheckMate 238 trial confirmed the superior efficacy of nivolumab compared with ipilimumab in patients with stage III and IV resected melanoma.

T-cell redirection therapy shows durable response for metastatic uveal melanoma

Immunocore Limited presented data from the IMCgp100-102 trial at the American Society of Clinical Oncology meeting that showed a durable response and strong overall survival rate in patients with metastatic uveal melanoma.

Cancer in the News

Feature Articles

Melanoma remains Australia’s ‘national cancer’ with 14,000 diagnosed each year

Mandy Johnson believes that she owes her life to a 90-second online test.

Read the full story

Posted in Melanoma In The News, Patient Information

Every cancer patient should be prescribed exercise medicine

Every four minutes someone in Australia is diagnosed with cancer.

Read the full story

Posted in Melanoma In The News, Latest News

Cancer-killing viruses show promise and draw billion-dollar investment

Pharmaceutical giant Johnson & Johnson announced on 2 May that it would pay up to US$1 billion to acquire a company that makes cancer-killing viruses.

Read the full story

Posted in Melanoma In The News, Information

Cancer Council NSW: Melanoma survivors at increased risk of prostate cancer

A NEW Cancer Council NSW study has found men who survived melanoma are at a 25 per cent increased risk of a prostate cancer diagnosis later in life, highlighting the importance of sun protection.

Read the full story

Posted in Melanoma In The News, Patient Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories